Literature DB >> 23515602

Clinical analysis in 202 children with juvenile idiopathic arthritis.

Hui Huang1, Xiaoqing Qian, Haiguo Yu, Juan Li, Yayuan Zhang.   

Abstract

This study attempts to characterize the clinical features of various subtypes of juvenile idiopathic arthritis (JIA) and try to investigate the prognostic factors. Patients with JIA hospitalized in Nanjing Children Hospital during April 2005 to April 2010 were enrolled. Clinical manifestations and laboratory parameters were retrospectively reviewed. A total of 202 cases were included, 105 males and 97 females, with average age at onset of 7.5 years. Patients with systemic JIA were most common, accounting for 47.0%. Fever, rash, and arthritis were the most common clinical manifestations. The most commonly involved joints were the knee and ankle. Laboratory parameters were significantly different but not specific. Time from onset to treatment, hepatomegaly, and involvement of wrist may have a significant effect on the outcome. A total of 117 cases were followed up, with an average follow-up time of 2 years. Among them, 55 cases achieved complete remission, 27 cases with partial remission, and 29 cases without remission, and six died. JIA is a heterogeneous disease with varied onset and clinical manifestations, which makes treatment a serious challenge. Receiving treatment late, hepatomegaly, and impaired wrist were early risk factors for an unfavorable outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23515602     DOI: 10.1007/s10067-013-2232-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

Review 1.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

2.  Juvenile idiopathic arthritis among Nigerians: a case study.

Authors:  Olufemi O Adelowo; A Umar
Journal:  Clin Rheumatol       Date:  2010-03-01       Impact factor: 2.980

Review 3.  Juvenile idiopathic arthritis.

Authors:  Berent Prakken; Salvatore Albani; Alberto Martini
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

4.  Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.

Authors:  Xuefeng B Ling; Jane L Park; Tanya Carroll; Khoa D Nguyen; Kenneth Lau; Claudia Macaubas; Edward Chen; Tzielan Lee; Christy Sandborg; Diana Milojevic; John T Kanegaye; Susanna Gao; Jane Burns; James Schilling; Elizabeth D Mellins
Journal:  Proteomics       Date:  2010-11-23       Impact factor: 3.984

Review 5.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

Review 6.  Toward an understanding of the long-term outcome of juvenile idiopathic arthritis.

Authors:  A Ravelli
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

Review 7.  Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases.

Authors:  Antonio G Tristano
Journal:  Med Sci Monit       Date:  2008-03

Review 8.  Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis.

Authors:  C Stephen Foster
Journal:  Curr Opin Ophthalmol       Date:  2003-12       Impact factor: 3.761

Review 9.  MRI in juvenile idiopathic arthritis and juvenile dermatomyositis.

Authors:  Janet Mary McCrae Gardner-Medwin; Greg Irwin; Karl Johnson
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

10.  Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).

Authors:  Edward M Behrens; Timothy Beukelman; Lisa Gallo; Julie Spangler; Margalit Rosenkranz; Thaschawee Arkachaisri; Rosanne Ayala; Brandt Groh; Terri H Finkel; Randy Q Cron
Journal:  J Rheumatol       Date:  2007-12-15       Impact factor: 4.666

View more
  6 in total

1.  Evaluation of children with juvenile idiopathic arthritis in southeastern Turkey: a single center experience.

Authors:  V Şen; A Ece; Ü Uluca; A Güneş; S Yel; I Tan; D Karabel; B Yıldırım; K Haspolat
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 2.  Clinical Outcome and Long-term Remission in JIA.

Authors:  Mia Glerup; T Herlin; M Twilt
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

3.  STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C polymorphisms influence the risk of developing juvenile idiopathic arthritis in Han Chinese patients.

Authors:  Zhi-Dan Fan; Fei-Fei Wang; Hui Huang; Na Huang; Hui-Hui Ma; Yi-Hong Guo; Ya-Yuan Zhang; Xiao-Qing Qian; Hai-Guo Yu
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

4.  A Novel Method for Pathway Identification Based on Attractor and Crosstalk in Polyarticular Juvenile Idiopathic Arthritis.

Authors:  Yuanji Wang; Shunhua Lin; Changhui Li; Yizhao Li; Lei Chen; Yingzhen Wang
Journal:  Med Sci Monit       Date:  2016-11-02

Review 5.  The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.

Authors:  Nataša Toplak; Štefan Blazina; Tadej Avčin
Journal:  Drug Des Devel Ther       Date:  2018-06-08       Impact factor: 4.162

6.  Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study.

Authors:  Jeong Yun Choi; Jee Eun Chung; Ji Hyun Park; Yoon Sook Cho; Yong Woo Jung; Soo An Choi
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.